MEDICINOVA, INC. Capital Expenditures
MEDICINOVA, INC. (MNOV) reported Capital Expenditures of $10.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $10.82K.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.90K, a 48216.67% increase year-over-year.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $2.90K, a 223.91% increase from fiscal 2024.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $895.00, a 95.80% decline from fiscal 2023.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $21.30K, a 325.13% increase from fiscal 2022.
- MEDICINOVA, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $5.01K, a 82.56% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 129 month | Payments to Acquire Property, Plant, and Equipment 132 month | Payments to Acquire Property, Plant, and Equipment 135 month | Payments to Acquire Property, Plant, and Equipment 138 month | Payments to Acquire Property, Plant, and Equipment 141 month | Payments to Acquire Property, Plant, and Equipment 144 month | Payments to Acquire Property, Plant, and Equipment 147 month | Payments to Acquire Property, Plant, and Equipment 150 month | Payments to Acquire Property, Plant, and Equipment 153 month | Payments to Acquire Property, Plant, and Equipment 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $10.82K 10-Q · filed 2026-08-13 | $10.82K derived: sum of 3 quarters · filed 2026-08-13 | $13.72K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2026-03-31 | $10.82K 10-Q · filed 2026-05-14 | $10.82K derived: sum of 2 quarters · filed 2026-05-14 | $13.72K derived: sum of 3 quarters · filed 2026-05-14 | $13.72K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.90K derived: sum of 2 quarters · filed 2026-03-10 | $2.90K derived: sum of 3 quarters · filed 2026-08-13 | $2.90K 10-K · filed 2026-03-10 | ||||||||||
| 2025-09-30 | $2.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.90K derived: sum of 2 quarters · filed 2026-08-13 | $2.90K 10-Q · filed 2025-11-12 | $2.90K derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | -$2.00 derived: sum of 3 quarters · filed 2026-08-13 | $4.00 derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | -$2.00 derived: sum of 2 quarters · filed 2026-05-14 | $4.00 derived: sum of 3 quarters · filed 2026-05-14 | |||||||||||
| 2024-12-31 | -$2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.00 derived: sum of 2 quarters · filed 2026-03-10 | $895.00 10-K · filed 2026-03-10 | |||||||||||
| 2024-09-30 | $6.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $897.00 10-Q · filed 2025-11-12 | ||||||||||||
| 2024-06-30 | $891.00 10-Q · filed 2025-08-14 | |||||||||||||
| 2023-12-31 | -$22.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $2.72K derived: sum of 2 quarters · filed 2025-02-19 | $21.30K 10-K · filed 2025-02-19 | |||||||||||
| 2023-09-30 | $2.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $21.32K 10-Q · filed 2024-11-13 | ||||||||||||
| 2023-06-30 | $18.58K 10-Q · filed 2024-08-08 | |||||||||||||
| 2022-12-31 | $5.01K 10-K · filed 2024-02-15 | |||||||||||||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | $2.94K derived: sum of 2 quarters · filed 2023-03-28 | $28.73K 10-K/A · filed 2023-03-28 | |||||||||||
| 2021-09-30 | $2.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $28.73K 10-Q · filed 2022-11-10 | ||||||||||||
| 2021-06-30 | $25.79K 10-Q · filed 2022-08-11 | |||||||||||||
| 2020-12-31 | $32.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $33.89K derived: sum of 2 quarters · filed 2022-02-16 | $33.90K derived: sum of 3 quarters · filed 2022-02-16 | $36.49K 10-K · filed 2022-02-16 | ||||||||||
| 2020-09-30 | $1.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.20K derived: sum of 2 quarters · filed 2021-11-12 | $3.79K 10-Q · filed 2021-11-12 | $11.05K derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | $10.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.60K 10-Q · filed 2021-08-12 | $9.86K derived: sum of 3 quarters · filed 2021-08-12 | $9.86K derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||
| 2020-03-31 | $2.59K 10-Q · filed 2021-05-13 | $9.85K derived: sum of 2 quarters · filed 2021-05-13 | $9.85K derived: sum of 3 quarters · filed 2021-05-13 | $11.91K derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||
| 2019-12-31 | $7.26K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $7.26K derived: sum of 2 quarters · filed 2021-02-19 | $9.32K derived: sum of 3 quarters · filed 2021-02-19 | $11.27K 10-K · filed 2021-02-19 | ||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $2.06K derived: sum of 2 quarters · filed 2020-10-26 | $4.01K 10-Q · filed 2020-10-26 | $4.01K derived: sum of 4 quarters · filed 2020-10-26 | ||||||||||
| 2019-06-30 | $2.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $4.01K 10-Q · filed 2020-07-28 | $4.01K derived: sum of 3 quarters · filed 2020-07-28 | $4.01K derived: sum of 4 quarters · filed 2020-07-28 | ||||||||||
| 2019-03-31 | $1.95K 10-Q · filed 2020-04-23 | $1.95K derived: sum of 2 quarters · filed 2020-04-23 | $1.95K derived: sum of 3 quarters · filed 2020-04-23 | $3.57K derived: sum of 4 quarters · filed 2020-04-23 | ||||||||||
| 2018-12-31 | -$7.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$7.00 derived: sum of 2 quarters · filed 2020-02-13 | $1.62K derived: sum of 3 quarters · filed 2020-02-13 | $10.20K 10-K · filed 2020-02-13 | ||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | $1.62K derived: sum of 2 quarters · filed 2019-10-24 | $10.21K 10-Q · filed 2019-10-24 | |||||||||||
| 2018-06-30 | $1.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $10.21K 10-Q · filed 2019-07-25 | ||||||||||||
| 2018-03-31 | $8.58K 10-Q · filed 2019-04-25 | |||||||||||||
| 2016-12-31 | $17.64K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $51.35K derived: sum of 2 quarters · filed 2019-02-13 | $62.48K derived: sum of 3 quarters · filed 2019-02-13 | $84.48K 10-K · filed 2019-02-13 | ||||||||||
| 2016-09-30 | $33.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | $44.84K derived: sum of 2 quarters · filed 2017-10-23 | $66.84K 10-Q · filed 2017-10-23 | $66.84K derived: sum of 4 quarters · filed 2018-02-13 | ||||||||||
| 2016-06-30 | $11.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $33.13K 10-Q · filed 2017-07-26 | $33.13K derived: sum of 3 quarters · filed 2018-02-13 | |||||||||||
| 2016-03-31 | $22.00K 10-Q · filed 2017-04-26 | $22.00K derived: sum of 2 quarters · filed 2018-02-13 | ||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $2.32K 10-K · filed 2018-02-13 | ||||||||||||
| 2015-09-30 | $2.32K 10-Q · filed 2016-10-25 | |||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | $3.52K 10-K · filed 2017-02-14 | ||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 derived: sum of 2 quarters · filed 2015-10-29 | $3.52K 10-Q · filed 2015-10-29 | $15.76K derived: sum of 4 quarters · filed 2015-10-29 | ||||||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $3.52K 10-Q · filed 2015-07-30 | $15.76K derived: sum of 3 quarters · filed 2015-07-30 | $755.00 derived: sum of 4 quarters · filed 2015-07-30 | ||||||||||
| 2014-03-31 | $3.52K 10-Q · filed 2015-05-11 | $15.76K derived: sum of 2 quarters · filed 2015-05-11 | $755.00 derived: sum of 3 quarters · filed 2015-05-11 | $45.08K derived: sum of 4 quarters · filed 2015-05-11 | ||||||||||
| 2013-12-31 | $12.24K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$2.77K derived: sum of 2 quarters · filed 2015-03-12 | $41.55K derived: sum of 3 quarters · filed 2015-03-12 | $41.55K 10-K · filed 2015-03-12 | ||||||||||
| 2013-09-30 | -$15.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $29.31K derived: sum of 2 quarters · filed 2014-11-13 | $29.31K 10-Q · filed 2014-11-13 | $29.52K derived: sum of 4 quarters · filed 2014-11-13 | $2.39M 10-Q · filed 2013-11-07 | |||||||||
| 2013-06-30 | $44.32K derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08 | $44.32K 10-Q · filed 2014-08-13 | $44.52K derived: sum of 3 quarters · filed 2014-03-27 | $78.36K derived: sum of 4 quarters · filed 2014-03-27 | $2.41M 10-Q · filed 2013-08-08 | |||||||||
| 2013-03-31 | $0.00 derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08 | $202.00 derived: sum of 2 quarters · filed 2014-03-27 | $34.04K derived: sum of 3 quarters · filed 2014-03-27 | $75.35K derived: sum of 4 quarters · filed 2014-03-27 | $2.36M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $202.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $34.04K derived: sum of 2 quarters · filed 2014-03-27 | $75.35K derived: sum of 3 quarters · filed 2014-03-27 | $83.38K 10-K · filed 2014-03-27 | $2.36M 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | $33.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $75.15K derived: sum of 2 quarters · filed 2013-11-07 | $83.18K 10-Q · filed 2013-11-07 | $89.26K derived: sum of 4 quarters · filed 2013-11-07 | $2.36M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | $41.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $49.34K 10-Q · filed 2013-08-08 | $55.42K derived: sum of 3 quarters · filed 2013-08-08 | $55.42K derived: sum of 4 quarters · filed 2013-08-08 | $2.33M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | $8.02K 10-Q · filed 2013-05-08 | $14.11K derived: sum of 2 quarters · filed 2013-05-08 | $14.11K derived: sum of 3 quarters · filed 2013-05-08 | $2.29M 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | $6.08K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $6.08K derived: sum of 2 quarters · filed 2013-03-28 | $6.08K 10-K · filed 2013-03-28 | $2.28M 10-K · filed 2012-03-29 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | $2.27M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | $2.27M 10-Q · filed 2011-08-15 | ||||||||||||
| 2010-12-31 | $4.26K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $11.46K derived: sum of 2 quarters · filed 2012-03-29 | $18.56K 10-K · filed 2012-03-29 | |||||||||||
| 2010-09-30 | $7.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $14.30K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $7.10K 10-Q · filed 2011-08-15 | |||||||||||||
| 2009-12-31 | $16.45K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |